Cargando…
Can non-invasively detected liver fibrosis using serum-based scores really improve risk stratification in patients with acute coronary syndrome?
Autores principales: | Steffen, Hans-Michael, Martin, Anna, Lang, Sonja, Kasper, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293380/ https://www.ncbi.nlm.nih.gov/pubmed/37118637 http://dx.doi.org/10.1007/s00392-023-02212-5 |
Ejemplares similares
-
Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022) -
Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016) -
Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification
por: Huang, Weiting, et al.
Publicado: (2021) -
Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021) -
Development of a Non-Invasive Liver Fibrosis Score Based on Transient Elastography for Risk Stratification in Patients with Type 2 Diabetes
por: Lee, Chi-Ho, et al.
Publicado: (2021)